Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Siilo is a European digital health company that built a secure, compliant messaging and collaboration platform for healthcare professionals. Its products have been used by clinicians and care teams to communicate about patient cases, share medical knowledge, and coordinate care through encrypted mobile and web-based workflows. The company expanded from a standalone medical messenger into organizational collaboration tools for hospitals and care networks. In March 2023, Siilo was acquired by Doctolib, and the product later evolved under the Doctolib Siilo brand before being renamed Doctolib Connect in November 2025. Siilo is therefore best understood as an acquired healthtech collaboration platform rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Siilo.